|
chr3_-_87122958
|
3.738
|
|
VGLL3
|
vestigial like 3 (Drosophila)
|
|
chr3_-_87122936
|
3.391
|
NM_016206
|
VGLL3
|
vestigial like 3 (Drosophila)
|
|
chr14_+_100362236
|
1.573
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
chr14_+_100362204
|
1.483
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
chr1_+_22107137
|
1.150
|
|
RPL21
|
ribosomal protein L21
|
|
chr14_-_51605515
|
1.006
|
|
NID2
|
nidogen 2 (osteonidogen)
|
|
chr12_+_56406296
|
0.671
|
|
LOC100130776
|
hypothetical LOC100130776
|
|
chr18_-_12647736
|
0.588
|
|
SPIRE1
|
spire homolog 1 (Drosophila)
|
|
chr18_-_12647911
|
0.505
|
NM_001128626
NM_020148
|
SPIRE1
|
spire homolog 1 (Drosophila)
|
|
chr7_-_27149750
|
0.494
|
NM_019102
|
HOXA5
|
homeobox A5
|
|
chr1_+_216585298
|
0.464
|
NM_001135599
NM_003238
|
TGFB2
|
transforming growth factor, beta 2
|
|
chr1_-_143706265
|
0.451
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
chr3_+_30623376
|
0.412
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
chr9_+_130173418
|
0.396
|
NM_001135947
NM_030914
|
URM1
|
ubiquitin related modifier 1
|
|
chr14_-_51605487
|
0.356
|
|
NID2
|
nidogen 2 (osteonidogen)
|
|
chr18_+_12648191
|
0.323
|
|
|
|
|
chr9_+_130173458
|
0.285
|
|
URM1
|
ubiquitin related modifier 1
|
|
chr13_+_96884316
|
0.246
|
NM_021033
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
chr1_-_143706196
|
0.235
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
chr17_-_68100537
|
0.234
|
|
LOC100499467
|
hypothetical LOC100499467
|
|
chr1_-_1283770
|
0.210
|
NM_032348
|
MXRA8
|
matrix-remodelling associated 8
|
|
chr1_-_224441023
|
0.181
|
|
ACBD3
|
acyl-CoA binding domain containing 3
|
|
chr3_+_30622905
|
0.166
|
NM_001024847
NM_003242
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
chr2_-_150152482
|
0.137
|
|
MMADHC
|
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria
|
|
chr6_+_116798791
|
0.124
|
NM_013352
|
DSE
|
dermatan sulfate epimerase
|
|
chr2_-_150152531
|
0.119
|
NM_015702
|
MMADHC
|
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria
|
|
chr11_-_5766621
|
0.115
|
NM_001001913
|
OR52N1
|
olfactory receptor, family 52, subfamily N, member 1
|
|
chr1_-_224441024
|
0.114
|
NM_022735
|
ACBD3
|
acyl-CoA binding domain containing 3
|
|
chr19_-_49076080
|
0.097
|
NM_001033719
|
ZNF404
|
zinc finger protein 404
|
|
chr10_+_59698891
|
0.096
|
NM_018464
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
chr18_-_5882102
|
0.092
|
NM_001080209
|
TMEM200C
|
transmembrane protein 200C
|
|
chr1_-_2447848
|
0.090
|
NM_018216
|
PANK4
|
pantothenate kinase 4
|
|
chr16_+_24475129
|
0.084
|
|
RBBP6
|
retinoblastoma binding protein 6
|
|
chr2_-_150152361
|
0.084
|
|
MMADHC
|
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria
|
|
chr6_+_30632641
|
0.071
|
|
PRR3
|
proline rich 3
|
|
chr20_+_41519947
|
0.057
|
|
SRSF6
|
serine/arginine-rich splicing factor 6
|
|
chr3_+_113763561
|
0.052
|
NM_017945
|
SLC35A5
|
solute carrier family 35, member A5
|
|
chr11_+_93917214
|
0.043
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
chr10_-_103869923
|
0.039
|
NM_001113407
|
LDB1
|
LIM domain binding 1
|
|
chr8_+_12914143
|
0.023
|
NM_001099677
|
KIAA1456
|
KIAA1456
|
|
chr17_+_7328412
|
0.021
|
NM_000937
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
chr19_-_10287673
|
0.017
|
NM_001031734
|
FDX1L
|
ferredoxin 1-like
|
|
chr22_-_16127520
|
0.016
|
|
CECR3
|
cat eye syndrome chromosome region, candidate 3
|
|
chr19_-_9074981
|
0.014
|
NM_001005193
|
OR7G2
|
olfactory receptor, family 7, subfamily G, member 2
|
|
chr7_-_6713066
|
0.010
|
NM_006956
NM_016265
|
ZNF12
|
zinc finger protein 12
|
|
chr7_+_6713228
|
0.006
|
|
|
|
|
chr17_+_38250122
|
0.004
|
NM_001158
NM_009590
|
AOC2
|
amine oxidase, copper containing 2 (retina-specific)
|
|
chr5_+_170747543
|
0.003
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
